Why is Kilitch Drugs falling/rising?

As of 15-Sep, Kilitch Drugs (India) Ltd is experiencing a decline in its stock price, currently at Rs 352.00, which represents a decrease of Rs 8.35 or 2.32%. The stock has been underperforming, having lost 4.4% over the last three days and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the stock's delivery volume has decreased significantly, falling by 45% against the 5-day average, indicating reduced investor participation. Over the past week, the stock has declined by 4.09%, and over the past month, it has fallen by 18.56%, contrasting with the Sensex, which has gained 1.24% and 1.47% respectively.
In the broader market context, Kilitch Drugs' recent performance starkly contrasts with the benchmark index, as it has underperformed significantly in the short term. While the Sensex has shown positive returns, Kilitch Drugs has faced a notable downturn, particularly in the last month and week. Despite a year-to-date gain of 8.98%, the stock's longer-term performance over one year shows a decline of 9.87%, further highlighting its recent struggles compared to the Sensex's slight decline of 1.33% over the same period. This combination of declining stock price, reduced trading activity, and poor short-term performance relative to the benchmark suggests a challenging environment for Kilitch Drugs at this time.